DSM Biomedical, a global solutions provider in biomedical science and regenerative medicine, today announced a new partnership with the Musculoskeletal Transplant Foundation (MTF), a non-profit service organization, to distribute biologic products for use in plastic and reconstructive surgery. The partnership will address the changing needs of hospitals and providers by offering a full suite of biologic products.
DSM is a developer and manufacturer of xenograft meshes and synthetic materials used in plastic and reconstructive surgeries. These products complement the portfolio of allograft meshes and materials offered by MTF already being distributed to Plastic and Reconstructive Surgeons.
“We are excited to partner with MTF, benefitting from their deep understanding of biologic and regenerative products and their exemplary reputation for quality and safety,” says Tim Shannon, Business Director, Orthopedics & Soft Tissue, DSM Biomedical.
“MTF’s partnership with DSM Biomedical is yet another step forward in enhancing our presence in Plastic and Reconstructive Surgery”, says Tom Shaffer, Executive Vice President of Global Sales and Marketing, MTF. “DSM offers significant expertise in the development of regenerative biomaterials that align with MTF’s current biologics portfolio. We are excited to collaborate with DSM on the development and delivery of innovative biomaterials that serve the unmet clinical needs of patients worldwide”